Regulation of the Hippo pathway and implications for anticancer drug development

Hyun Woo Park, Kun Liang Guan

Research output: Contribution to journalReview article

62 Citations (Scopus)

Abstract

Research in the past decade has revealed key components of the Hippo tumor suppressor pathway and its critical role in organ size regulation and tumorigenesis. Recent progress has identified a wide range of upstream factors that control the Hippo pathway, which include cell-cell contact, various diffusible signals, and cognate receptors. Dysregulation of the Hippo pathway, caused by gene mutation or aberrant expression, promotes cell proliferation and tumorigenesis. Here, we discuss the current state of Hippo pathway research, primarily focusing on upstream regulators and protein-protein interactions as potential therapeutic targets. Consideration of pharmacological intervention of the Hippo pathway may provide novel avenues for future therapeutic treatment of human diseases, particularly in cancer.

Original languageEnglish
Pages (from-to)581-589
Number of pages9
JournalTrends in Pharmacological Sciences
Volume34
Issue number10
DOIs
Publication statusPublished - 2013 Oct 1

Fingerprint

Carcinogenesis
Critical Pathways
Organ Size
Cell proliferation
Research
Pharmaceutical Preparations
Tumors
Neoplasms
Proteins
Genes
Cell Proliferation
Pharmacology
Mutation
Therapeutics

All Science Journal Classification (ASJC) codes

  • Toxicology
  • Pharmacology

Cite this

@article{763acbf5c42d41e4823deff999b3dd21,
title = "Regulation of the Hippo pathway and implications for anticancer drug development",
abstract = "Research in the past decade has revealed key components of the Hippo tumor suppressor pathway and its critical role in organ size regulation and tumorigenesis. Recent progress has identified a wide range of upstream factors that control the Hippo pathway, which include cell-cell contact, various diffusible signals, and cognate receptors. Dysregulation of the Hippo pathway, caused by gene mutation or aberrant expression, promotes cell proliferation and tumorigenesis. Here, we discuss the current state of Hippo pathway research, primarily focusing on upstream regulators and protein-protein interactions as potential therapeutic targets. Consideration of pharmacological intervention of the Hippo pathway may provide novel avenues for future therapeutic treatment of human diseases, particularly in cancer.",
author = "Park, {Hyun Woo} and Guan, {Kun Liang}",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.tips.2013.08.006",
language = "English",
volume = "34",
pages = "581--589",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "10",

}

Regulation of the Hippo pathway and implications for anticancer drug development. / Park, Hyun Woo; Guan, Kun Liang.

In: Trends in Pharmacological Sciences, Vol. 34, No. 10, 01.10.2013, p. 581-589.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Regulation of the Hippo pathway and implications for anticancer drug development

AU - Park, Hyun Woo

AU - Guan, Kun Liang

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Research in the past decade has revealed key components of the Hippo tumor suppressor pathway and its critical role in organ size regulation and tumorigenesis. Recent progress has identified a wide range of upstream factors that control the Hippo pathway, which include cell-cell contact, various diffusible signals, and cognate receptors. Dysregulation of the Hippo pathway, caused by gene mutation or aberrant expression, promotes cell proliferation and tumorigenesis. Here, we discuss the current state of Hippo pathway research, primarily focusing on upstream regulators and protein-protein interactions as potential therapeutic targets. Consideration of pharmacological intervention of the Hippo pathway may provide novel avenues for future therapeutic treatment of human diseases, particularly in cancer.

AB - Research in the past decade has revealed key components of the Hippo tumor suppressor pathway and its critical role in organ size regulation and tumorigenesis. Recent progress has identified a wide range of upstream factors that control the Hippo pathway, which include cell-cell contact, various diffusible signals, and cognate receptors. Dysregulation of the Hippo pathway, caused by gene mutation or aberrant expression, promotes cell proliferation and tumorigenesis. Here, we discuss the current state of Hippo pathway research, primarily focusing on upstream regulators and protein-protein interactions as potential therapeutic targets. Consideration of pharmacological intervention of the Hippo pathway may provide novel avenues for future therapeutic treatment of human diseases, particularly in cancer.

UR - http://www.scopus.com/inward/record.url?scp=84885182528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885182528&partnerID=8YFLogxK

U2 - 10.1016/j.tips.2013.08.006

DO - 10.1016/j.tips.2013.08.006

M3 - Review article

C2 - 24051213

AN - SCOPUS:84885182528

VL - 34

SP - 581

EP - 589

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 10

ER -